Ovarian Cancer: Bevacizumab

(asked on 9th October 2026) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has been made of access to bevacizumab for women with recurrent ovarian cancer who have previously received the treatment and whether consideration has been given to making bevacizumab available off license for such patients where clinically appropriate.


Answered by
James Frith Portrait
James Frith
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 15th October 2026

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Reticulating Splines